UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

BMC cancer, 2015-03, Vol.15 (1), p.127-127, Article 127

2015

Link zum Volltext

Verfügbarkeit prüfen

224 MuciLight trial: phase 2 of LED photobiomodulation for treatment of mucositis in oral cavity or oropharyngeal cancer

Radiotherapy and oncology, 2024-03, Vol.192, p.S274-S275

2024

Link zum Volltext

Verfügbarkeit prüfen

Reappraisal of eligibility criteria in cancer clinical trials

Current opinion in oncology, 2018-09, Vol.30 (5), p.352-357

2018

Link zum Volltext

Verfügbarkeit prüfen

Évolution du cadre réglementaire de la recherche clinique

Bulletin du cancer, 2019-04, Vol.106, p.389-394

2019

Link zum Volltext

Verfügbarkeit prüfen

Is ovarian recovery after chemotherapy in young patients with early breast cancer influenced by controlled ovarian hyperstimulation for fertility preservation or tumor characteristics? Results of a prospective study in 126 patients

International journal of cancer, 2022-06, Vol.150 (11), p.1850-1860

2022

Link zum Volltext

Verfügbarkeit prüfen

Évolution du cadre réglementaire de la recherche clinique

Bulletin du cancer, 2019-04, Vol.106 (4), p.389-394

2019

Link zum Volltext

Verfügbarkeit prüfen

Preoperative chemoradiation (CRT) with carboplatin (CBP)/paclitaxel (PCL) (CP) or with 5-fluorouracil (FU)/oxaliplatin (OX) (Fx) for esophageal or junctional cancer: A randomized phase 2 trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4015-4015

2022

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of herbal medicine (HM) use among breast cancer patients treated with chemotherapy, hormone therapy, or targeted therapy

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13108-e13108

2018

Link zum Volltext

Verfügbarkeit prüfen

Reporting adverse events in cancer surgery randomized trials: A systematic review of published trials in oesophago-gastric and gynecological cancer patients

Critical reviews in oncology/hematology, 2016-08, Vol.104, p.108-114

2016

Link zum Volltext

Verfügbarkeit prüfen

Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgery

ESMO open, 2021-04, Vol.6 (2), p.100098-100098, Article 100098

2021

Link zum Volltext

Verfügbarkeit prüfen

“TNM” at study entry in phase I trials

Bulletin du cancer, 2021-06, Vol.108 (6), p.671-672

2021

Link zum Volltext

Verfügbarkeit prüfen

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib (REG) in patients (pts) with nonadipocytic soft tissue sarcoma (STS) previously treated with pazopanib (PAZ)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.11021-11021

2019

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel once weekly (wP) combined with fixed dose of oral metronomic cyclophosphamide (OMC): A dose-escalating phase I trial

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e14015-e14015

2017

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors, Morbidity, and Quality of Life Associated with Same-Day Discharge in Gynecologic Oncology

Indian journal of gynecologic oncology, 2020-03, Vol.18 (1), Article 35

2020

Link zum Volltext

Verfügbarkeit prüfen

Rego-SARC: Activity and safety of regorafenib (RE) in patients with metastatic soft-tissue sarcoma (STS) previously treated with anthracyclin-based chemotherapy—A multinational, randomized, placebo-controlled phase II trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS10602-TPS10602

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors among cancer patients with good performance status screened for phase I trials

Investigational new drugs, 2008-02, Vol.26 (1), p.53-58

2008

Link zum Volltext

Verfügbarkeit prüfen

Imaging of the most frequent superficial soft-tissue sarcomas

Skeletal radiology, 2011-03, Vol.40 (3), p.271-284

2011

Link zum Volltext

Verfügbarkeit prüfen

Frequency of Certain Established Risk Factors in Soft Tissue Sarcomas in Adults: A Prospective Descriptive Study of 658 Cases

Sarcoma, 2008, Vol.2008, p.459386-6

2008

Link zum Volltext

Verfügbarkeit prüfen

Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas

Bulletin du cancer, 2003-10, Vol.90 (10), p.887

2003

Link zum Volltext

Verfügbarkeit prüfen

Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors

Cancer research (Chicago, Ill.), 1991-10, Vol.51 (19), p.5384-5391

1991

Link zum Volltext

Verfügbarkeit prüfen

Association head and neck angiosarcoma and nevoid basal cell carcinoma syndrome (Gorlin syndrome)

Oral oncology extra, 2005-11, Vol.41 (10), p.289-291

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

224 MuciLight trial: phase 2 of LED photobiomodulation for treatment of mucositis in oral cavity or oropharyngeal cancer

Reappraisal of eligibility criteria in cancer clinical trials

Évolution du cadre réglementaire de la recherche clinique

Is ovarian recovery after chemotherapy in young patients with early breast cancer influenced by controlled ovarian hyperstimulation for fertility preservation or tumor characteristics? Results of a prospective study in 126 patients

Évolution du cadre réglementaire de la recherche clinique

Preoperative chemoradiation (CRT) with carboplatin (CBP)/paclitaxel (PCL) (CP) or with 5-fluorouracil (FU)/oxaliplatin (OX) (Fx) for esophageal or junctional cancer: A randomized phase 2 trial

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

Prevalence of herbal medicine (HM) use among breast cancer patients treated with chemotherapy, hormone therapy, or targeted therapy

Reporting adverse events in cancer surgery randomized trials: A systematic review of published trials in oesophago-gastric and gynecological cancer patients

Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgery

“TNM” at study entry in phase I trials

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib (REG) in patients (pts) with nonadipocytic soft tissue sarcoma (STS) previously treated with pazopanib (PAZ)

Paclitaxel once weekly (wP) combined with fixed dose of oral metronomic cyclophosphamide (OMC): A dose-escalating phase I trial

Risk Factors, Morbidity, and Quality of Life Associated with Same-Day Discharge in Gynecologic Oncology

Rego-SARC: Activity and safety of regorafenib (RE) in patients with metastatic soft-tissue sarcoma (STS) previously treated with anthracyclin-based chemotherapy—A multinational, randomized, placebo-controlled phase II trial

Prognostic factors among cancer patients with good performance status screened for phase I trials

Imaging of the most frequent superficial soft-tissue sarcomas

Frequency of Certain Established Risk Factors in Soft Tissue Sarcomas in Adults: A Prospective Descriptive Study of 658 Cases

Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas

Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors

Association head and neck angiosarcoma and nevoid basal cell carcinoma syndrome (Gorlin syndrome)

Suchergebnisse filtern